Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Tredje AP fonden

Tredje AP fonden lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 1.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,399 shares of the company’s stock after selling 605 shares during the quarter. Tredje AP fonden’s holdings in Cardinal Health were worth $3,775,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. J. W. Coons Advisors LLC grew its holdings in shares of Cardinal Health by 0.6% during the 4th quarter. J. W. Coons Advisors LLC now owns 16,680 shares of the company’s stock worth $1,681,000 after purchasing an additional 100 shares during the period. Edmonds Duncan Registered Investment Advisors LLC increased its position in shares of Cardinal Health by 5.0% in the first quarter. Edmonds Duncan Registered Investment Advisors LLC now owns 2,090 shares of the company’s stock worth $234,000 after acquiring an additional 100 shares in the last quarter. Midland Wealth Advisors LLC raised its stake in shares of Cardinal Health by 4.2% in the 2nd quarter. Midland Wealth Advisors LLC now owns 2,488 shares of the company’s stock valued at $245,000 after acquiring an additional 100 shares during the period. Aptus Capital Advisors LLC lifted its holdings in shares of Cardinal Health by 5.1% during the 2nd quarter. Aptus Capital Advisors LLC now owns 2,071 shares of the company’s stock valued at $204,000 after acquiring an additional 100 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its position in Cardinal Health by 0.5% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 20,891 shares of the company’s stock worth $2,054,000 after purchasing an additional 100 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

CAH opened at $111.40 on Thursday. Cardinal Health, Inc. has a 12-month low of $85.82 and a 12-month high of $116.05. The stock has a market capitalization of $27.13 billion, a PE ratio of 49.51, a P/E/G ratio of 1.55 and a beta of 0.60. The firm’s fifty day moving average price is $104.62 and its 200 day moving average price is $104.02.

Cardinal Health (NYSE:CAH) last issued its earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.10. The business had revenue of $59.87 billion for the quarter, compared to analyst estimates of $58.74 billion. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.55 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.61 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be given a $0.506 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, October 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.82%. Cardinal Health’s dividend payout ratio (DPR) is presently 89.78%.

Wall Street Analysts Forecast Growth

Several research firms have commented on CAH. Robert W. Baird raised their price objective on Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a research report on Thursday, August 15th. JPMorgan Chase & Co. raised their target price on Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Argus upped their price target on Cardinal Health from $115.00 to $125.00 and gave the stock a “buy” rating in a report on Wednesday, September 11th. Evercore ISI lifted their price objective on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research note on Thursday, August 15th. Finally, Morgan Stanley boosted their target price on shares of Cardinal Health from $114.00 to $119.00 and gave the stock an “overweight” rating in a research report on Thursday, August 15th. One analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $119.36.

Insider Activity

In related news, CFO Aaron E. Alt sold 2,323 shares of the firm’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.93. Following the transaction, the chief financial officer now directly owns 36,867 shares in the company, valued at $4,015,184.97. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Jason M. Hollar sold 46,455 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $109.02, for a total transaction of $5,064,524.10. Following the completion of the sale, the chief executive officer now owns 197,636 shares of the company’s stock, valued at approximately $21,546,276.72. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Aaron E. Alt sold 2,323 shares of the firm’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.93. Following the completion of the transaction, the chief financial officer now directly owns 36,867 shares in the company, valued at approximately $4,015,184.97. The disclosure for this sale can be found here. In the last ninety days, insiders sold 113,963 shares of company stock worth $12,379,980. 0.15% of the stock is currently owned by insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.